Exact claim · Version 1 · Reviewed 2026-07-23
“Sermorelin was once FDA-approved.”
A verdict on this wording and scope, not a universal grade for Sermorelin.
01 · Verdict
Supported with scope
Geref approvals are documented. FDA later determined that the discontinued products were not withdrawn for reasons of safety or effectiveness.
- Evidence basis
- Regulatory or product record
- Scope
- Historical Geref products, not current compounded sermorelin.
- Category
- Approval and status
02 · Primary record
Check the attached evidence
01Geref (sermorelin acetate) approval packageU.S. Food and Drug Administration · FDA review · 1991
Supports the scoped claim02FDA determination that Geref was not withdrawn for safety or effectivenessFederal Register · U.S. Food and Drug Administration · Regulatory · 2013
Supports the scoped claim
Supports the scoped claim02FDA determination that Geref was not withdrawn for safety or effectivenessFederal Register · U.S. Food and Drug Administration · Regulatory · 2013
Supports the scoped claim
- Editorial review
- Internal editorial review recorded
- Responsible editor
- Anthony Treviso · Founder and responsible editor
- Clinical-review boundary
- Not independently medically reviewed.